| 1 | Cross‐Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment | 12.7 | 12 | Citations (PDF) |
| 2 | Faecal microbiota transplantation (FMT): classical bedside-to-bench clinical research | 0.5 | 1 | Citations (PDF) |
| 3 | Human microbiome variance is underestimated | 7.0 | 31 | Citations (PDF) |
| 4 | Interpersonal variability of the human gut virome confounds disease signal detection in IBD | 4.4 | 24 | Citations (PDF) |
| 5 | Detailed mapping of Bifidobacterium strain transmission from mother to infant via a dual culture-based and metagenomic approach | 13.9 | 54 | Citations (PDF) |
| 6 | Altered Skin and Gut Microbiome in Hidradenitis Suppurativa | 2.3 | 78 | Citations (PDF) |
| 7 | Making computed tomography safer for patients with Crohn’s disease | 1.8 | 2 | Citations (PDF) |
| 8 | P493 The synthetic glycan KB295 optimises microbiome composition and function in ulcerative colitis: Results from a proof of principle human study | 1.3 | 0 | Citations (PDF) |
| 9 | Colorectal microbiota after removal of colorectal cancer | 2.8 | 8 | Citations (PDF) |
| 10 | The gut microbiome as a modulator of healthy ageing | 48.0 | 617 | Citations (PDF) |
| 11 | Metagenomic assembled plasmids of the human microbiome vary across disease cohorts | 3.5 | 14 | Citations (PDF) |
| 12 | Modulation, microbiota and inflammation in the adult CF gut: A prospective study | 0.8 | 17 | Citations (PDF) |
| 13 | The nonindustrialised microbiome in a modern world | 6.4 | 9 | Citations (PDF) |
| 14 | Ranking microbiome variance in inflammatory bowel disease: a large longitudinal
intercontinental study | 21.2 | 212 | Citations (PDF) |
| 15 | The Healthy Microbiome—What Is the Definition of a Healthy Gut Microbiome? | 1.0 | 320 | Citations (PDF) |
| 16 | The effects of sustained fitness improvement on the gut microbiome: A longitudinal, repeated measures case‐study approach | 1.5 | 29 | Citations (PDF) |
| 17 | The fecal mycobiome in patients with Irritable Bowel Syndrome | 3.5 | 42 | Citations (PDF) |
| 18 | Changing phenotype of inflammatory bowel disease and neglected metabolic health | 0.9 | 1 | Citations (PDF) |
| 19 | The gut virome in Irritable Bowel Syndrome differs from that of controls | 10.4 | 50 | Citations (PDF) |
| 20 | Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis | 5.1 | 38 | Citations (PDF) |
| 21 | The undesirable resilience of the pejorative term “castrate-resistant prostate cancer” | 1.3 | 0 | Citations (PDF) |
| 22 | Inflammasome Signaling Regulates the Microbial–Neuroimmune Axis and Visceral Pain in Mice | 4.5 | 12 | Citations (PDF) |
| 23 | A Convolutional Neural Network Deep Learning Model Trained on CD Ulcers Images Accurately Identifies NSAID Ulcers | 2.6 | 13 | Citations (PDF) |
| 24 | Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftor | 0.8 | 39 | Citations (PDF) |
| 25 | TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells | 8.7 | 153 | Citations (PDF) |
| 26 | 244 MICROBIOME ANALYSIS OF UPPER DIGESTIVE TRACT BIOPSY SAMPLES FROM INDIVIDUALS ALONG THE METAPLASIA-DYSPLASIA-ADENOCARCINOMA SEQUENCE. | 0.5 | 0 | Citations (PDF) |
| 27 | The effect of immunosuppression on patch testing: A cross‐sectional study in patients with inflammatory bowel disease | 2.0 | 1 | Citations (PDF) |
| 28 | Macronutrients, microbiome and precision nutrition | 2.3 | 14 | Citations (PDF) |
| 29 | Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption | 1.0 | 174 | Citations (PDF) |
| 30 | Impaired cognitive function in Crohn’s disease: Relationship to disease activity | 2.5 | 16 | Citations (PDF) |
| 31 | Investigating the Role of Diet and Exercise in Gut Microbe-Host Cometabolism | 4.5 | 16 | Citations (PDF) |
| 32 | Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection | 9.9 | 65 | Citations (PDF) |
| 33 | Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease | 13.9 | 252 | Citations (PDF) |
| 34 | Human BCL-G regulates secretion of inflammatory chemokines but is dispensable for induction of apoptosis by IFN-γ and TNF-α in intestinal epithelial cells | 8.7 | 24 | Citations (PDF) |
| 35 | Piphillin predicts metagenomic composition and dynamics from DADA2-corrected 16S rDNA sequences | 3.3 | 68 | Citations (PDF) |
| 36 | Defining gastrointestinal transit time using video capsule endoscopy: a study of healthy subjects | 1.7 | 35 | Citations (PDF) |
| 37 | Encapsulated cyclosporine does not change the composition of the human microbiota when assessed ex vivo and in vivo | 1.7 | 17 | Citations (PDF) |
| 38 | Gut microbiota alterations associated with reduced bone mineral density in older adults | 2.0 | 165 | Citations (PDF) |
| 39 | Host Microbiota Regulates Central Nervous System Serotonin Receptor 2C Editing in Rodents | 3.8 | 11 | Citations (PDF) |
| 40 | Bifidobacterium breve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers | 1.0 | 69 | Citations (PDF) |
| 41 | Friendship in medicine: the Corrigan Club considers its demise | 0.5 | 0 | Citations (PDF) |
| 42 | Translating the gut microbiome: ready for the clinic? | 48.0 | 43 | Citations (PDF) |
| 43 | Four men in a boat: Ultra-endurance exercise alters the gut microbiome | 2.4 | 103 | Citations (PDF) |
| 44 | Letter: dietary fibre benefits for the oesophagus—physical rather than metabolic action? Authors’ reply | 3.9 | 3 | Citations (PDF) |
| 45 | Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial | 2.4 | 68 | Citations (PDF) |
| 46 | Review article: dietary fibre in the era of microbiome science | 3.9 | 144 | Citations (PDF) |
| 47 | The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial | 3.6 | 32 | Citations (PDF) |
| 48 | The Gut Microbiota in Causation, Detection, and Treatment of Cancer | 0.7 | 31 | Citations (PDF) |
| 49 | A Bifidobacterial pilus‐associated protein promotes colonic epithelial proliferation | 2.6 | 74 | Citations (PDF) |
| 50 | How to swim with sharks: a perspective on Voltaire Cousteau’s primer | 0.5 | 0 | Citations (PDF) |
| 51 | Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence | 1.3 | 310 | Citations (PDF) |
| 52 | A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults | 4.5 | 193 | Citations (PDF) |
| 53 | Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn’s Disease and Ulcerative Colitis | 1.3 | 115 | Citations (PDF) |
| 54 | CORK Study in Cystic FibrosisChest, 2018, 153, 395-403 | 1.1 | 88 | Citations (PDF) |
| 55 | The oral microbiota in colorectal cancer is distinctive and predictive | 21.2 | 563 | Citations (PDF) |
| 56 | Dietary Fiber and Gastrointestinal Disease: an Evolving Story | 2.7 | 9 | Citations (PDF) |
| 57 | The Use of a Mini-Bioreactor Fermentation System as a Reproducible, High-Throughput ex vivo Batch Model of the Distal Colon | 3.9 | 51 | Citations (PDF) |
| 58 | Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection | 2.4 | 89 | Citations (PDF) |
| 59 | Carbohydrate Syntrophy enhances the establishment of Bifidobacterium breve UCC2003 in the neonatal gut | 3.5 | 26 | Citations (PDF) |
| 60 | Low-dose CT imaging of the acute abdomen using model-based iterative reconstruction: a prospective study | 1.3 | 17 | Citations (PDF) |
| 61 | The Gut Microbiota in Inflammatory Bowel Disease | 3.3 | 78 | Citations (PDF) |
| 62 | Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat | 3.5 | 33 | Citations (PDF) |
| 63 | Tumour-associated and non-tumour-associated microbiota in colorectal cancer | 21.2 | 752 | Citations (PDF) |
| 64 | The effect of exercise interventions on inflammatory biomarkers in healthy, physically inactive subjects: a systematic review | 0.5 | 52 | Citations (PDF) |
| 65 | Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection | 0.8 | 27 | Citations (PDF) |
| 66 | Mechansims Underpinning Successful Faecal Microbiota Transplantation (FMT) for Recurrent Clostridium Difficile Infection | 1.0 | 1 | Citations (PDF) |
| 67 | The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles | 3.4 | 62 | Citations (PDF) |
| 68 | Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E−/− mice | 11.5 | 93 | Citations (PDF) |
| 69 | Microbial regulation of hippocampal miRNA expression: Implications for transcription of kynurenine pathway enzymes | 2.3 | 63 | Citations (PDF) |
| 70 | Feeding the microbiota: transducer of nutrient signals for the host | 21.2 | 143 | Citations (PDF) |
| 71 | A randomised, double-blind, placebo-controlled clinical study: the effects of a synbiotic, Lepicol, in adults with chronic, functional constipation | 3.2 | 24 | Citations (PDF) |
| 72 | Microbial regulation of microRNA expression in the amygdala and prefrontal cortex | 11.5 | 169 | Citations (PDF) |
| 73 | The microbiome regulates amygdala-dependent fear recall | 8.4 | 179 | Citations (PDF) |
| 74 | GREB1 genetic variants are associated with bone mineral density in Caucasians | 1.9 | 10 | Citations (PDF) |
| 75 | The Changing Phenotype of Inflammatory Bowel Disease | 1.4 | 13 | Citations (PDF) |
| 76 | Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk | 2.4 | 126 | Citations (PDF) |
| 77 | Adult microbiota‐deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus | 3.6 | 307 | Citations (PDF) |
| 78 | Pure Iterative Reconstruction Improves Image Quality in Computed Tomography of the Abdomen and Pelvis Acquired at Substantially Reduced Radiation Doses in Patients With Active Crohn Disease | 1.1 | 7 | Citations (PDF) |
| 79 | Microbial contributions to chronic inflammation and metabolic disease | 3.2 | 22 | Citations (PDF) |
| 80 | Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma? | 3.5 | 60 | Citations (PDF) |
| 81 | Regulation of prefrontal cortex myelination by the microbiota | 5.5 | 577 | Citations (PDF) |
| 82 | Preparation of a standardised faecal slurry for ex-vivo microbiota studies which reduces inter-individual donor bias | 1.8 | 35 | Citations (PDF) |
| 83 | Exercise, fitness, and the gut | 2.3 | 44 | Citations (PDF) |
| 84 | Su1939 Neuro-Immune Changes in IBS: A Link Between Microbiota, TLRs and Sensory-Related Markers? | 1.0 | 0 | Citations (PDF) |
| 85 | 260 Alterations in the Microbiota in Irritable Bowel Syndrome; A Comparison of Two Geographically Distinct Cohorts | 1.0 | 6 | Citations (PDF) |
| 86 | Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene | 1.3 | 237 | Citations (PDF) |
| 87 | IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation | 7.1 | 127 | Citations (PDF) |
| 88 | In the performing art of medicine: the doctor as actor | 0.5 | 1 | Citations (PDF) |
| 89 | Quantitative analysis of mucosal oxygenation using ex vivo imaging of healthy and inflamed mammalian colon tissue | 5.6 | 23 | Citations (PDF) |
| 90 | Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10‐year follow‐up confirms prognostic significance | 2.7 | 6 | Citations (PDF) |
| 91 | Dietary<i>trans</i>-10,<i>cis</i>-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice | 2.5 | 99 | Citations (PDF) |
| 92 | Model-Based Iterative Reconstruction in CT Enterography | 4.2 | 18 | Citations (PDF) |
| 93 | Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers | 21.2 | 269 | Citations (PDF) |
| 94 | Microbes & neurodevelopment – Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala | 4.7 | 241 | Citations (PDF) |
| 95 | Separating the microbiome from the hyperbolome | 9.7 | 12 | Citations (PDF) |
| 96 | The small bowel microbiota | 2.3 | 26 | Citations (PDF) |
| 97 | The microbiota in inflammatory bowel disease | 4.5 | 223 | Citations (PDF) |
| 98 | Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial | 2.4 | 109 | Citations (PDF) |
| 99 | The metabolic role of the microbiota | 1.4 | 3 | Citations (PDF) |
| 100 | Fiber man meets microbial man | 4.9 | 26 | Citations (PDF) |
| 101 | Concomitant Exposure to Ovalbumin and Endotoxin Augments Airway Inflammation but Not Airway Hyperresponsiveness in a Murine Model of Asthma | 2.4 | 24 | Citations (PDF) |
| 102 | The utilisation and diagnostic yield of radiological imaging in a specialist functional GI disorder clinic: an 11-year retrospective study | 3.7 | 4 | Citations (PDF) |
| 103 | Identification of a Unique Hybrid Macrophage-Polarization State following Recovery from Lipopolysaccharide Tolerance | 0.6 | 68 | Citations (PDF) |
| 104 | Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk | 10.4 | 125 | Citations (PDF) |
| 105 | The impact of probiotics in obese pregnancy to reduce maternal fasting glucose: A randomized controlled trial | 0.7 | 1 | Citations (PDF) |
| 106 | Effect of phylloquinone (vitamin K<sub>1</sub>) supplementation for 12 months on the indices of vitamin K status and bone health in adult patients with Crohn's disease | 2.5 | 21 | Citations (PDF) |
| 107 | Gastric digestion of α-lactalbumin in adult human subjects using capsule endoscopy and nasogastric tube sampling | 2.5 | 27 | Citations (PDF) |
| 108 | The sustained trajectory of small bowel research | 2.3 | 0 | Citations (PDF) |
| 109 | Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory | 4.2 | 98 | Citations (PDF) |
| 110 | Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn’s disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B) | 3.0 | 10 | Citations (PDF) |
| 111 | Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies | 1.0 | 160 | Citations (PDF) |
| 112 | Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study) | 4.9 | 149 | Citations (PDF) |
| 113 | Gut microbiota modulation and implications for host health: Dietary strategies to influence the gut–brain axis | 6.8 | 56 | Citations (PDF) |
| 114 | Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract | 3.0 | 44 | Citations (PDF) |
| 115 | Exopolysaccharide-Producing Probiotic Lactobacilli Reduce Serum Cholesterol and Modify Enteric Microbiota in ApoE-Deficient Mice | 3.0 | 91 | Citations (PDF) |
| 116 | Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut | 7.6 | 561 | Citations (PDF) |
| 117 | Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats | 2.4 | 251 | Citations (PDF) |
| 118 | Gut microbiota and obesity: Role in aetiology and potential therapeutic target | 3.0 | 99 | Citations (PDF) |
| 119 | Ethereal and material gain: unanticipated opportunity with illness or disability | 1.4 | 0 | Citations (PDF) |
| 120 | Exercise and associated dietary extremes impact on gut microbial diversity | 21.2 | 1,260 | Citations (PDF) |
| 121 | The role of pure iterative reconstruction in conventional dose CT enterography | 2.0 | 13 | Citations (PDF) |
| 122 | Bcl-3 deficiency protects against dextran-sodium sulphate-induced colitis in the mouse | 3.5 | 23 | Citations (PDF) |
| 123 | Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis | 24.2 | 95 | Citations (PDF) |
| 124 | Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an <i>in vivo</i> model of colon cancer | 4.5 | 24 | Citations (PDF) |
| 125 | A prospective feasibility study of sub-millisievert abdominopelvic CT using iterative reconstruction in Crohn’s disease | 3.7 | 43 | Citations (PDF) |
| 126 | The Neglected Spectrum of Diverticular-related Disorders | 6.2 | 3 | Citations (PDF) |
| 127 | Identification of TLR10 as a Key Mediator of the Inflammatory Response to <i>Listeria monocytogenes</i> in Intestinal Epithelial Cells and Macrophages | 0.6 | 109 | Citations (PDF) |
| 128 | Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity | 21.2 | 254 | Citations (PDF) |
| 129 | Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system | 11.1 | 70 | Citations (PDF) |
| 130 | Bifidobacterium infantis suppression of Peyer’s patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers | 2.6 | 40 | Citations (PDF) |
| 131 | Natural killer cells protect mice from DSS-induced colitis by regulating neutrophil function via the NKG2A receptor | 7.1 | 62 | Citations (PDF) |
| 132 | Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission | 3.0 | 326 | Citations (PDF) |
| 133 | In praise of the literary eponym--Henry V sign | 0.5 | 2 | Citations (PDF) |
| 134 | Digestion of epithelial tight junction proteins by the commensal<i>Clostridium perfringens</i> | 3.4 | 22 | Citations (PDF) |
| 135 | A Randomized Controlled Study of Mesalamine After Acute Diverticulitis | 2.4 | 116 | Citations (PDF) |
| 136 | The colonic microbiota in health and disease | 2.3 | 93 | Citations (PDF) |
| 137 | Natural Killer Cells Protect against Mucosal and Systemic Infection with the Enteric Pathogen Citrobacter rodentium | 2.7 | 58 | Citations (PDF) |
| 138 | Risk factors for hand injury in hurling: a cross-sectional study | 2.0 | 7 | Citations (PDF) |
| 139 | <i><i>Bifidobacterium infantis</i></i>35624 modulates host inflammatory processes beyond the gut | 10.4 | 435 | Citations (PDF) |
| 140 | Prevalence and characterization of Clostridium perfringens from the faecal microbiota of elderly Irish subjects | 1.7 | 50 | Citations (PDF) |
| 141 | Movers and shakers | 10.4 | 278 | Citations (PDF) |
| 142 | Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge | 2.4 | 147 | Citations (PDF) |
| 143 | Depth-Dependent Differences in Community Structure of the Human Colonic Microbiota in Health | 2.4 | 25 | Citations (PDF) |
| 144 | Microbiota is essential for social development in the mouse | 8.4 | 818 | Citations (PDF) |
| 145 | Shining a Light on Intestinal Traffic | 3.5 | 8 | Citations (PDF) |
| 146 | Bacteriophages ϕMR299-2 and ϕNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells | 4.4 | 238 | Citations (PDF) |
| 147 | Role of Radiologic Imaging in Irritable Bowel Syndrome: Evidence-based Review | 8.9 | 36 | Citations (PDF) |
| 148 | In Search of Lost Opportunities: Marcel Proyce and James Joust Discuss Doctors, Diseases, Life and Death (a Hypothetical Conversation between Marcel Proust and James Joyce) | 0.4 | 1 | Citations (PDF) |
| 149 | <i>Bifidobacterium infantis</i>35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells | 21.2 | 272 | Citations (PDF) |
| 150 | The gut microbiota and its relationship to diet and obesity | 10.4 | 433 | Citations (PDF) |
| 151 | Shanahan's Response to Hayman Regarding Darwinian Dyspepsia | 0.7 | 0 | Citations (PDF) |
| 152 | Bifidobacterium Infantis 35624 Protects Against Salmonella -Induced Reductions in Digestive Enzyme Activity in Mice by Attenuation of the Host Inflammatory Response | 2.9 | 44 | Citations (PDF) |
| 153 | Darwinian Dyspepsia: An Extraordinary Scientist, an Ordinary Illness, Great Dignity | 0.7 | 12 | Citations (PDF) |
| 154 | Carriage of Clostridium difficile in outpatients with irritable bowel syndrome | 1.7 | 18 | Citations (PDF) |
| 155 | Minimization of Radiation Exposure due to Computed Tomography in Inflammatory Bowel Disease | 1.4 | 16 | Citations (PDF) |
| 156 | The Sphingosine-1-Phosphate Analogue FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium | 2.7 | 27 | Citations (PDF) |
| 157 | Radiologic Imaging in Cystic FibrosisChest, 2012, 141, 1575-1583 | 1.1 | 83 | Citations (PDF) |
| 158 | World Gastroenterology Organisation Global Guidelines | 2.4 | 364 | Citations (PDF) |
| 159 | The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain | 5.9 | 34 | Citations (PDF) |
| 160 | Increased Risk of Miscarriage and Ectopic Pregnancy Among Women With Irritable Bowel Syndrome | 6.2 | 28 | Citations (PDF) |
| 161 | Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota | 4.9 | 110 | Citations (PDF) |
| 162 | Diagnostic Accuracy of Computed Tomography Using Lower Doses of Radiation for Patients With Crohn's Disease | 6.2 | 48 | Citations (PDF) |
| 163 | Probiotics in Transition | 6.2 | 35 | Citations (PDF) |
| 164 | Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse | 2.4 | 33 | Citations (PDF) |
| 165 | Mechanism of protection of transepithelial barrier function by<i>Lactobacillus salivarius</i>: strain dependence and attenuation by bacteriocin production | 3.4 | 83 | Citations (PDF) |
| 166 | The Colonic Microbiota and Colonic Disease | 2.7 | 25 | Citations (PDF) |
| 167 | Plain abdominal radiographs in patients with Crohn’s disease: Radiological findings and diagnostic value | 1.5 | 10 | Citations (PDF) |
| 168 | The gut microbiota—a clinical perspective on lessons learned | 48.0 | 95 | Citations (PDF) |
| 169 | Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection | 7.6 | 518 | Citations (PDF) |
| 170 | Radiation Exposure From Diagnostic Imaging Among Patients With Gastrointestinal Disorders | 6.2 | 44 | Citations (PDF) |
| 171 | Selection of Symptomatic Patients with Crohn's Disease for Abdominopelvic Computed Tomography: Role of Serum C-Reactive Protein | 2.6 | 7 | Citations (PDF) |
| 172 | A Commentary on the Safety of Probiotics | 3.3 | 62 | Citations (PDF) |
| 173 | Bifidobacterium breve with α-Linolenic Acid and Linoleic Acid Alters Fatty Acid Metabolism in the Maternal Separation Model of Irritable Bowel Syndrome | 2.4 | 32 | Citations (PDF) |
| 174 | Computed Tomography Assessment of Intestinal Gas Volumes in Functional Gastrointestinal Disorders | 2.4 | 12 | Citations (PDF) |
| 175 | Gut microbiota composition correlates with diet and health in the elderly | 38.7 | 3,034 | Citations (PDF) |
| 176 | Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota | 4.1 | 199 | Citations (PDF) |
| 177 | Differential intestinal M‐cell gene expression response to gut commensals | 4.8 | 24 | Citations (PDF) |
| 178 | CT‐based estimation of intracavitary gas volumes using threshold‐based segmentation: <i>In vitro</i> study to determine the optimal threshold range | 1.2 | 12 | Citations (PDF) |
| 179 | The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner | 8.4 | 1,738 | Citations (PDF) |
| 180 | Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome | 0.7 | 191 | Citations (PDF) |
| 181 | The Immunomodulatory Drug FTY720 Prevents Clearance of Citrobacter rodentium Infection in Mice | 1.0 | 0 | Citations (PDF) |
| 182 | Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation | 1.0 | 307 | Citations (PDF) |
| 183 | Minimization of radiation exposure due to computed tomography in inflammatory bowel disease | 1.9 | 12 | Citations (PDF) |
| 184 | MiR-146a Negatively Regulates IL-17A Inflammatory Response and is Elevated in Intestinal Epithelial Cells From Inflammatory Bowel Disease (IBD) Patients | 1.0 | 1 | Citations (PDF) |
| 185 | Stimulation of T-Cells in Irritable Bowel Syndrome (IBS) Mucosal Biopsy Tissue Releases Cytokines Which Selectively Activate Submucosal Neurons | 1.0 | 0 | Citations (PDF) |
| 186 | The colonic microflora and probiotic therapy in health and disease | 2.3 | 23 | Citations (PDF) |
| 187 | The effect of vitamin K1 supplementation for 12 months on bone mineral density and indices of vitamin K status and bone turnover in adult Crohn's disease patients | 0.7 | 0 | Citations (PDF) |
| 188 | Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome | 4.1 | 91 | Citations (PDF) |
| 189 | Degradation of the extracellular matrix components by bacterial-derived metalloproteases | 3.0 | 65 | Citations (PDF) |
| 190 | Who needs doctors? Staying fresh in changing times | 1.4 | 0 | Citations (PDF) |
| 191 | An unusual phenotype in Muckle-Wells syndrome associated with NLRP3 E311K | 2.0 | 6 | Citations (PDF) |
| 192 | The hybrid science of diet, microbes, and metabolic health | 4.9 | 28 | Citations (PDF) |
| 193 | Functional genome analysis of
<i>Bifidobacterium breve</i>
UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor | 7.6 | 361 | Citations (PDF) |
| 194 | Response to Sprakes et al. | 0.7 | 0 | Citations (PDF) |
| 195 | Managing chronic disease in Ireland: hospital admission rates and clinical outcomes in a large ulcerative colitis population | 1.3 | 7 | Citations (PDF) |
| 196 | Oral Administration of the Probiotic Bifidobacterium Infantis 35624 to Humans Induces Immunoregulatory Responses In Vivo | 0.7 | 0 | Citations (PDF) |
| 197 | Complementary Human mDC and pDC Mechanisms Ensure Induction of Foxp3+ T Cells in Response to the Commensal Microbiota | 0.7 | 0 | Citations (PDF) |
| 198 | Investigating physiological variation in healthy Irish adults using a combination of traditional techniques and emerging metabolomic technologies | 0.7 | 0 | Citations (PDF) |
| 199 | The effects of probiotic supplementation on gut microbiota composition, immunological and biochemical markers in healthy volunteers | 0.7 | 1 | Citations (PDF) |
| 200 | Impact of Administered <i>Bifidobacterium</i> on Murine Host Fatty Acid Composition | 1.4 | 75 | Citations (PDF) |
| 201 | Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo | 2.5 | 40 | Citations (PDF) |
| 202 | Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohnʼs disease | 3.0 | 45 | Citations (PDF) |
| 203 | Differential regulation of Toll‐like receptor signalling in spleen and Peyer’s patch dendritic cells | 4.8 | 26 | Citations (PDF) |
| 204 | 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Host–microbe interactions in the gut: target for drug therapy, opportunity for drug discovery | 3.5 | 17 | Citations (PDF) |
| 205 | Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease | 3.5 | 57 | Citations (PDF) |
| 206 | Use of bioluminescence imaging to track neutrophil migration and its inhibition in experimental colitis | 3.5 | 32 | Citations (PDF) |
| 207 | Irritable Bowel Syndrome Rates Following Organic Disease of Upper and Lower Gastrointestinal Tract | 0.7 | 1 | Citations (PDF) |
| 208 | Probiotic Colonization of the Adherent Mucus Layer of HT29MTXE12 Cells Attenuates
<i>Campylobacter jejuni</i>
Virulence Properties | 2.7 | 88 | Citations (PDF) |
| 209 | Technical Advance: Function and efficacy of an α4-integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis | 3.0 | 16 | Citations (PDF) |
| 210 | IBS: an epigenetic perspective | 48.0 | 82 | Citations (PDF) |
| 211 | Response to Andrews et al. | 0.7 | 0 | Citations (PDF) |
| 212 | Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders, from Rationale to Reality | 3.3 | 37 | Citations (PDF) |
| 213 | Probiotics in Perspective | 1.0 | 102 | Citations (PDF) |
| 214 | Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models | 21.2 | 895 | Citations (PDF) |
| 215 | Plasma Cytokine Profiles in Females With Irritable Bowel Syndrome and Extra-Intestinal Co-Morbidity | 0.7 | 150 | Citations (PDF) |
| 216 | Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation? | 0.7 | 214 | Citations (PDF) |
| 217 | Gut Microbes: From Bugs to Drugs | 0.7 | 52 | Citations (PDF) |
| 218 | Esophageal intramural pseudodiverticulosis characterized by barium esophagography: a case report | 0.9 | 8 | Citations (PDF) |
| 219 | Inflammatory bowel disease—From mechanisms to treatment strategies | 3.2 | 48 | Citations (PDF) |
| 220 | Induction and Activation of Adaptive Immune Populations During Acute and Chronic Phases of a Murine Model of Experimental Colitis | 2.3 | 99 | Citations (PDF) |
| 221 | Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8 | 2.3 | 178 | Citations (PDF) |
| 222 | Efficacy of Delayed-Release Mesalamine in the Prevention of GI Symptoms Following Acute Diverticulitis: Results of the DIVA Trial | 0.7 | 8 | Citations (PDF) |
| 223 | Exploring the Diversity of the Bifidobacterial Population in the Human Intestinal Tract | 3.5 | 291 | Citations (PDF) |
| 224 | The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission | 0.7 | 194 | Citations (PDF) |
| 225 | The emerging role of the microbial-gastrointestinal-neural axis | 0.7 | 5 | Citations (PDF) |
| 226 | Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues | 4.9 | 180 | Citations (PDF) |
| 227 | Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer | 2.4 | 93 | Citations (PDF) |
| 228 | The language of medicine: words as servants and scoundrels | 1.4 | 12 | Citations (PDF) |
| 229 | Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria | 2.5 | 54 | Citations (PDF) |
| 230 | Portrait of a canine probiotic Bifidobacterium—From gut to gut | 2.5 | 42 | Citations (PDF) |
| 231 | Cogan’s syndrome: present and future directions | 2.7 | 30 | Citations (PDF) |
| 232 | Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation | 4.8 | 14 | Citations (PDF) |
| 233 | Therapeutic implications of manipulating and mining the microbiota | 3.4 | 41 | Citations (PDF) |
| 234 | Microbiomic analysis of the bifidobacterial population in the human distal gut | 9.1 | 134 | Citations (PDF) |
| 235 | Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals | 2.8 | 125 | Citations (PDF) |
| 236 | Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection:<i>in vitro</i>and in murine models of intestinal disease | 3.1 | 13 | Citations (PDF) |
| 237 | Undiagnosed Maternal Celiac Disease in Pregnancy and an Increased Risk of Fetal Growth Restriction | 2.4 | 8 | Citations (PDF) |
| 238 | The effect of short-term phylloquinone supplementation on indices of vitamin K status and bone turnover in adult patients with Crohn's disease | 0.7 | 1 | Citations (PDF) |
| 239 | The evolving epidemiology of inflammatory bowel disease | 2.3 | 92 | Citations (PDF) |
| 240 | Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics | 1.3 | 39 | Citations (PDF) |
| 241 | A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome | 2.3 | 234 | Citations (PDF) |
| 242 | Don't forget increased risk of fetal growth restriction | 0.1 | 1 | Citations (PDF) |
| 243 | Bad language in gastroenterology | 2.7 | 1 | Citations (PDF) |
| 244 | From bugs to drugs—Mining the gut microbiota | 2.7 | 1 | Citations (PDF) |
| 245 | Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases | 21.2 | 249 | Citations (PDF) |
| 246 | Are patients with IBD knowledgeable about the risks of their medications? | 3.0 | 5 | Citations (PDF) |
| 247 | Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells | 5.7 | 36 | Citations (PDF) |
| 248 | Culture‐independent analysis of the gut microbiota in colorectal cancer and polyposis | 3.8 | 224 | Citations (PDF) |
| 249 | Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis | 3.8 | 14 | Citations (PDF) |
| 250 | The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions | 3.5 | 0 | Citations (PDF) |
| 251 | Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells | 3.5 | 33 | Citations (PDF) |
| 252 | Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis | 3.9 | 181 | Citations (PDF) |
| 253 | 43 The Role of T Cells in Vagal Protection Against Intestinal Inflammation | 1.0 | 1 | Citations (PDF) |
| 254 | Enhanced Cholinergic-Mediated Increase in the Pro-Inflammatory Cytokine IL-6 in Irritable Bowel Syndrome: Role of Muscarinic Receptors | 0.7 | 127 | Citations (PDF) |
| 255 | Mucosal cytokine imbalance in irritable bowel syndrome | 1.8 | 160 | Citations (PDF) |
| 256 | Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB Activation | 4.4 | 341 | Citations (PDF) |
| 257 | Protective effects of <i>Lactobacillus reuteri</i> and <i>Bifidobacterium infantis</i> in murine models for colitis do not involve the vagus nerve | 2.4 | 66 | Citations (PDF) |
| 258 | Crohn's disease: factors associated with exposure to high levels of diagnostic radiation | 21.2 | 324 | Citations (PDF) |
| 259 | Drug Interactions in Inflammatory Bowel Disease | 0.7 | 23 | Citations (PDF) |
| 260 | Dietary intakes and body composition in adult patients with long-standing Crohn's disease currently in remission | 0.7 | 0 | Citations (PDF) |
| 261 | James Joyce and gastroenterology | 1.4 | 4 | Citations (PDF) |
| 262 | Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains | 1.7 | 177 | Citations (PDF) |
| 263 | Probiotic Effects on Inflammatory Bowel Disease1, | 3.0 | 141 | Citations (PDF) |
| 264 | Intestinal tuberculosis mimicking Crohn??s disease: lessons relearned in a new era | 1.4 | 23 | Citations (PDF) |
| 265 | The normal intestinal microbiota | 3.5 | 121 | Citations (PDF) |
| 266 | Gut Microbiota: Mining for Therapeutic Potential | 6.2 | 122 | Citations (PDF) |
| 267 | The gut microbiota and disease – an inner repository for drug discovery | 0.4 | 11 | Citations (PDF) |
| 268 | Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease | 3.5 | 597 | Citations (PDF) |
| 269 | Mechanisms of Action of Probiotics in Intestinal Diseases | 3.0 | 106 | Citations (PDF) |
| 270 | Mucosal Cytokine Imbalance in Irritable Bowel Syndrome (IBS) | 0.7 | 1 | Citations (PDF) |
| 271 | <i>Salmonella typhimurium</i> stimulation combined with tumour-derived heat shock proteins induces potent dendritic cell anti-tumour responses in a murine model | 3.5 | 17 | Citations (PDF) |
| 272 | Prevalence of 5-ASA Use in Diverticulitis and Diverticulosis by Age and Gender | 0.7 | 0 | Citations (PDF) |
| 273 | CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss | 1.9 | 20 | Citations (PDF) |
| 274 | Probiotics in Inflammatory Bowel Disease | 0.5 | 1 | Citations (PDF) |
| 275 | Hypothalamic-Pituitary-Gut Axis Dysregulation in Irritable Bowel Syndrome: Plasma Cytokines as a Potential Biomarker? | 1.0 | 576 | Citations (PDF) |
| 276 | Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome | 0.7 | 776 | Citations (PDF) |
| 277 | Medicine in the Age of " Ulysses ": James Joyce's portrait of life, medicine, and disease on a Dublin day a century ago | 0.4 | 5 | Citations (PDF) |
| 278 | Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans | 3.4 | 92 | Citations (PDF) |
| 279 | Functional modulation of human intestinal epithelial cell responses by <i>Bifidobacterium infantis </i>and <i>Lactobacillus salivarius</i> | 4.8 | 257 | Citations (PDF) |
| 280 | Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use | 2.8 | 63 | Citations (PDF) |
| 281 | The gut flora as a forgotten organ | 5.2 | 2,505 | Citations (PDF) |
| 282 | Title is missing! | 4.0 | 16 | Citations (PDF) |
| 283 | Multireplicon genome architecture of Lactobacillus salivarius | 7.6 | 226 | Citations (PDF) |
| 284 | Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease | 4.1 | 285 | Citations (PDF) |
| 285 | Response to Dr. Kuenstner: More About MAP | 0.7 | 0 | Citations (PDF) |
| 286 | A strategy for obtaining near full-length HCV cDNA clones (assemblicons) by assembly PCR | 1.7 | 4 | Citations (PDF) |
| 287 | Correlation of probioticLactobacillus salivariusgrowth phase with its cell wall-associated proteome | 1.9 | 50 | Citations (PDF) |
| 288 | Targeting the Fas/Fas ligand pathway in cancer | 3.9 | 56 | Citations (PDF) |
| 289 | Physiological Basis for Novel Drug Therapies Used to Treat the Inflammatory Bowel Diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease | 3.4 | 71 | Citations (PDF) |
| 290 | Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles | 1.0 | 1,346 | Citations (PDF) |
| 291 | CON: Surveillance for Ulcerative Colitis-Associated Cancer: Time to Change the Endoscopy and the Microscopy | 0.7 | 12 | Citations (PDF) |
| 292 | Celiac Disease and the Transition from Childhood to Adulthood: A 28-Year Follow-Up | 0.7 | 80 | Citations (PDF) |
| 293 | Vitamin K Status in Patients with Crohn's Disease and Relationship to Bone Turnover | 0.7 | 75 | Citations (PDF) |
| 294 | Host–Flora Interactions in Inflammatory Bowel Disease | 3.0 | 61 | Citations (PDF) |
| 295 | Antibiotics as a First-line Therapy for Crohnʼs Disease | 3.0 | 6 | Citations (PDF) |
| 296 | Probiotics in inflammatory bowel disease—therapeutic rationale and role | 15.6 | 112 | Citations (PDF) |
| 297 | The role of substance P in inflammatory disease | 4.2 | 718 | Citations (PDF) |
| 298 | Mechanisms of adherence of a probioticLactobacillusstrain during and afterin vivoassessment in ulcerative colitis patients | 1.6 | 20 | Citations (PDF) |
| 299 | Clinical Examination of the Gastrointestinal System in the 21st Century-Is the Emphasis Right? | 0.7 | 1 | Citations (PDF) |
| 300 | Bacterial DNA within Granulomas of Patients with Crohn's Disease-Detection by Laser Capture Microdissection and PCR | 0.7 | 161 | Citations (PDF) |
| 301 | Persistence of hepatitis C virus in a white population: Associations with human leukocyte antigen class 1 | 1.0 | 36 | Citations (PDF) |
| 302 | Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy | 1.6 | 29 | Citations (PDF) |
| 303 | Title is missing! | 4.4 | 9 | Citations (PDF) |
| 304 | Manipulation of the bacterial flora in inflammatory bowel disease | 3.0 | 48 | Citations (PDF) |
| 305 | Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cellsin vivo | 4.5 | 25 | Citations (PDF) |
| 306 | Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P | 4.2 | 46 | Citations (PDF) |
| 307 | Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects | 3.0 | 159 | Citations (PDF) |
| 308 | Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression | 5.7 | 44 | Citations (PDF) |
| 309 | Association of NOD2 with Crohn's Disease in a homogenous Irish population | 3.2 | 77 | Citations (PDF) |
| 310 | Effective therapy for advanced gastrointestinal stromal tumors | 1.0 | 1 | Citations (PDF) |
| 311 | Screening for asymptomatic celiac disease among patients referred for bone densitometry measurement | 3.6 | 31 | Citations (PDF) |
| 312 | Bacterial DNA within granulomas of patients with Crohn's disease-detection by laser capture microdissection and PCR | 1.0 | 3 | Citations (PDF) |
| 313 | Probiotics: A Perspective on Problems and Pitfalls | 1.8 | 42 | Citations (PDF) |
| 314 | Exploring the Iceberg-the Spectrum of Celiac Disease | 0.7 | 17 | Citations (PDF) |
| 315 | Is nutrition an aetiological factor for inflammatory bowel disease? | 1.4 | 83 | Citations (PDF) |
| 316 | Acromegaly and Colorectal Cancer: A Comprehensive Review of Epidemiology, Biological Mechanisms, and Clinical Implications | 1.9 | 106 | Citations (PDF) |
| 317 | Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future | 2.5 | 64 | Citations (PDF) |
| 318 | Genotoxicity of Fecal Water in a Free-Living Irish Population | 2.5 | 11 | Citations (PDF) |
| 319 | A Randomised Controlled Trial of a Probiotic Lactobacillus Strain in Healthy Adults: Assessment of its Delivery, Transit and Influence on Microbial Flora and Enteric Immunity | 1.6 | 42 | Citations (PDF) |
| 320 | Role of probiotics in the treatment of intestinal infections and inflammation | 2.3 | 22 | Citations (PDF) |
| 321 | Soluble interleukin 2 receptor levels in families of people with schizophrenia | 2.4 | 30 | Citations (PDF) |
| 322 | Viral discrimination and subversion of host defense at the epithelial gateway | 1.0 | 0 | Citations (PDF) |
| 323 | Celiac disease and irritable bowel-type symptoms | 0.7 | 131 | Citations (PDF) |
| 324 | Crohn's disease | 52.8 | 480 | Citations (PDF) |
| 325 | The survival and colonic adhesion of Bifidobacterium infantis in patients with ulcerative colitis | 3.4 | 32 | Citations (PDF) |
| 326 | Coeliac disease and autoimmune Addison's disease: a clinical pitfall | 0.5 | 72 | Citations (PDF) |
| 327 | Food allergies | 2.7 | 14 | Citations (PDF) |
| 328 | Investigation of the Genetic Influence of the OPG, VDR (Fok1), and COLIA1 Sp1 Polymorphisms on BMD in the Irish Population | 2.9 | 69 | Citations (PDF) |
| 329 | Sulfate-Reducing Bacteria Colonize Pouches Formed for Ulcerative Colitis but Not for Familial Adenomatous Polyposis | 1.8 | 122 | Citations (PDF) |
| 330 | Biological behaviour and clinical implications of micrometastases | 0.4 | 72 | Citations (PDF) |
| 331 | Activation of the p38 MAPK and ERK1/2 Pathways Is Required for Fas‐Induced IL‐8 Production in Colonic Epithelial Cells | 4.1 | 20 | Citations (PDF) |
| 332 | Type I Insulin‐like Growth Factor Receptor Expression on Colorectal Adenocarcinoma Cell Lines Is Decreased in Response to the Chemopreventive Agent <i>N</i>‐Acetyl‐l‐Cysteine | 4.1 | 9 | Citations (PDF) |
| 333 | The host–microbe interface within the gut | 3.0 | 239 | Citations (PDF) |
| 334 | Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics | 1.0 | 329 | Citations (PDF) |
| 335 | Turbo probiotics for IBD | 1.0 | 14 | Citations (PDF) |
| 336 | Mutant Salmonella as vectors for gene therapy | 1.0 | 3 | Citations (PDF) |
| 337 | Upregulation of Fas-Fas-L (CD95/CD95L)-Mediated Epithelial Apoptosis—A Putative Role in Pouchitis? | 1.6 | 21 | Citations (PDF) |
| 338 | p53 at the crossroads of colitis and cancer | 1.0 | 3 | Citations (PDF) |
| 339 | Strategy for the maximization of clinically relevant information from hepatitis C virus, RT-PCR quantification | 3.1 | 3 | Citations (PDF) |
| 340 | Why is Celiac Disease So Common in Ireland? | 0.4 | 24 | Citations (PDF) |
| 341 | In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings | 4.9 | 716 | Citations (PDF) |
| 342 | Inferred Hepatitis C Virus Quasispecies Diversity Is Influenced by Choice of DNA Polymerase in Reverse Transcriptase-Polymerase Chain Reactions | 2.4 | 22 | Citations (PDF) |
| 343 | HLA class II genes determine the natural variance of hepatitis C viral load | 10.6 | 50 | Citations (PDF) |
| 344 | Tumour necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families | 3.8 | 84 | Citations (PDF) |
| 345 | Response to Dr. Gonzalez Cueto | 0.7 | 1 | Citations (PDF) |
| 346 | Anemia in patients with chronic inflammatory bowel disease | 0.7 | 64 | Citations (PDF) |
| 347 | Tissue viral load variability in chronic hepatitis C | 0.7 | 33 | Citations (PDF) |
| 348 | Constitutive ERK1/2 Activation in Esophagogastric Rib Bone Marrow Micrometastatic Cells Is MEK-independent | 2.2 | 43 | Citations (PDF) |
| 349 | Anti-TNF Therapy for Crohnʼs Disease: A Perspective (Infliximab Is Not the Drug We Have Been Waiting For) | 3.0 | 12 | Citations (PDF) |
| 350 | Probiotics and Inflammatory Bowel Disease: Is There a Scientific Rationale? | 3.0 | 152 | Citations (PDF) |
| 351 | Bone‐marrow micrometastases in patients with brain metastases from epithelial cell tumours | 0.5 | 2 | Citations (PDF) |
| 352 | Interferon-? sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis | 4.2 | 57 | Citations (PDF) |
| 353 | Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study | 10.6 | 51 | Citations (PDF) |
| 354 | Viral clearance in hepatitis C (1b) infection: Relationship with human leukocyte antigen class II in a homogeneous population | 10.6 | 65 | Citations (PDF) |
| 355 | V. Mechanisms of immunologic sensation of intestinal contents | 3.4 | 44 | Citations (PDF) |
| 356 | Colorectal cancer: still a major killer despite progress on many fronts | 0.5 | 4 | Citations (PDF) |
| 357 | Differential Expression of Neurokinin-1 Receptor by Human Mucosal and Peripheral Lymphoid Cells | 3.0 | 41 | Citations (PDF) |
| 358 | The Inflammatory Response Within Dukes' B Colorectal Cancers: Implications for Progression of Micrometastases and Patient Survival | 0.7 | 46 | Citations (PDF) |
| 359 | Bone Marrow Micrometastases and Gastrointestinal Cancer Detection and Significance | 0.7 | 20 | Citations (PDF) |
| 360 | Pregnancy and pregnancy outcome in hepatitis C type 1b | 0.5 | 55 | Citations (PDF) |
| 361 | <i>Helicobacter pylori</i>Modulates Lymphoepithelial Cell Interactions Leading to Epithelial Cell Damage through Fas/Fas Ligand Interactions | 2.7 | 102 | Citations (PDF) |
| 362 | Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation | 21.2 | 125 | Citations (PDF) |
| 363 | Esophagogastric cancer-time to change the paradigm | 0.7 | 2 | Citations (PDF) |
| 364 | The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia | 0.5 | 329 | Citations (PDF) |
| 365 | Gene therapy for food allergy | 1.0 | 3 | Citations (PDF) |
| 366 | How do intestinal T cells sense the dietary and microbial environment? | 1.0 | 2 | Citations (PDF) |
| 367 | Turning on T–Cell death and turning off Crohn's disease | 1.0 | 5 | Citations (PDF) |
| 368 | Altered Mechanisms of Apoptosis in Colon Cancer: Fas Resistance and Counterattack in the Tumor‐Immune Conflict | 4.1 | 93 | Citations (PDF) |
| 369 | Probiotics and inflammatory bowel disease: Is there a scientific rationale? | 3.0 | 62 | Citations (PDF) |
| 370 | Anti-tnf therapy for Crohn's disease: A perspective (infliximab is not the drug we have been waiting for) | 3.0 | 5 | Citations (PDF) |
| 371 | Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer | 21.2 | 126 | Citations (PDF) |
| 372 | An International Survey of The Use and Attitudes Regarding Alternative Medicine by Patients With Inflammatory Bowel Disease | 0.7 | 119 | Citations (PDF) |
| 373 | The Fas counterattack: cancer as a site of immune privilege | 7.7 | 223 | Citations (PDF) |
| 374 | Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover | 0.5 | 21 | Citations (PDF) |
| 375 | Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack | 0.5 | 29 | Citations (PDF) |
| 376 | Title is missing! | 1.5 | 327 | Citations (PDF) |
| 377 | Title is missing! | 2.8 | 14 | Citations (PDF) |
| 378 | Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population | 10.6 | 92 | Citations (PDF) |
| 379 | Probiotics: towards demonstrating efficacy | 15.3 | 81 | Citations (PDF) |
| 380 | Glial cells, mucosal integrity, and inflammatory bowel disease | 1.0 | 3 | Citations (PDF) |
| 381 | Micrometastases in esophagogastric cancer: High detection rate in resected rib segments | 1.0 | 170 | Citations (PDF) |
| 382 | Setback for systemic therapy of esophageal cancer: Right concept, disappointing result | 1.0 | 4 | Citations (PDF) |
| 383 | Escape from the Smad world by colon cancer | 1.0 | 2 | Citations (PDF) |
| 384 | The gastrointestinal system and psychological factors | 4.4 | 2 | Citations (PDF) |
| 385 | Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege | 3.0 | 46 | Citations (PDF) |
| 386 | Neuroimmunomodulation in Inflammatory Bowel Disease: How Far from “Bench” to “Bedside”?a | 4.1 | 33 | Citations (PDF) |
| 387 | Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer 1998, 186, 240-246 | | 113 | Citations (PDF) |
| 388 | Immuno-epithelial interactions: Cytokine modulation of normal rabbit colonocyte function | 1.5 | 1 | Citations (PDF) |
| 389 | Genes, bacteria, and T cells: Ingredients for inflammatory bowel disease | 1.0 | 10 | Citations (PDF) |
| 390 | Enteropathogenic E. coli: Intimacy redefined | 1.0 | 0 | Citations (PDF) |
| 391 | A significant step in the celiac puzzle | 1.0 | 3 | Citations (PDF) |
| 392 | Cytokine induced expression of substance P (NK-1) receptors in human colonic epithelial cells | 1.0 | 1 | Citations (PDF) |
| 393 | Fas ligand expression by normal human esophageal squamous epithelium: Another site of immune privilege | 1.0 | 4 | Citations (PDF) |
| 394 | Increased soluble interleukin 2 receptor levels in schizophrenia | 2.4 | 37 | Citations (PDF) |
| 395 | Coeliac disease and epilepsy | 0.5 | 83 | Citations (PDF) |
| 396 | Antibody 'markers' in Crohn's disease: opportunity or overstatement? | 21.2 | 19 | Citations (PDF) |
| 397 | Histological patchiness and sparing of the rectum in ulcerative colitis: refuting the dogma. | 2.0 | 10 | Citations (PDF) |
| 398 | Micrometastases: marker of metastatic potential or evidence of residual disease? | 21.2 | 102 | Citations (PDF) |
| 399 | Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden | 0.5 | 191 | Citations (PDF) |
| 400 | Innate resistance to <i>Listeria monocytogenes</i> in tumor-bearing mice | 3.0 | 1 | Citations (PDF) |
| 401 | Designer drugs for inflammatory bowel disease | 1.0 | 3 | Citations (PDF) |
| 402 | Quantification of the placebo response in ulcerative colitis | 1.0 | 127 | Citations (PDF) |
| 403 | Progress in treating esophageal adenocarcinoma | 1.0 | 13 | Citations (PDF) |
| 404 | The Fas Counterattack: A Molecular Mechanism of Tumor Immune Privilege | 5.8 | 55 | Citations (PDF) |
| 405 | Appropriateness of laboratory tests: Requests for atypical pneumonia serology in a teaching hospital | 1.3 | 2 | Citations (PDF) |
| 406 | From basic advances to therapeutic strategies in ulcerative colitis | 0.5 | 0 | Citations (PDF) |
| 407 | Discontent with Dysplasia Surveillance in Ulcerative Colitis | 3.0 | 6 | Citations (PDF) |
| 408 | Non-linkage of a T-Cell Receptor γ Chain Microsatellite ( D7S485 ) to Rheumatoid Arthritis in Multiplex Families | 6.7 | 2 | Citations (PDF) |
| 409 | Micrometastases in bone marrow of patients undergoing “curative” surgery for gastrointestinal cancer | 1.0 | 55 | Citations (PDF) |
| 410 | Patchiness of mucosal inflammation in treated ulcerative colitis: A prospective study | 1.9 | 220 | Citations (PDF) |
| 411 | Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis | 5.0 | 190 | Citations (PDF) |
| 412 | Immunosppressive Agents in Inflammatory Bowel Disease: Current Status and Future Prospects | 1.9 | 0 | Citations (PDF) |
| 413 | Current concepts of the pathogenesis of inflammatory bowel disease | 1.3 | 14 | Citations (PDF) |
| 414 | Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity | 2.3 | 36 | Citations (PDF) |
| 415 | Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? | 52.8 | 603 | Citations (PDF) |
| 416 | Neutrophil autoantibodies in inflammatory Bowel disease: Are they important? | 1.0 | 34 | Citations (PDF) |
| 417 | Gene-targeted immunologic knockouts: New models of inflammatory bowel disease | 1.0 | 9 | Citations (PDF) |
| 418 | Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. | 21.2 | 327 | Citations (PDF) |
| 419 | Pathogenesis of ulcerative colitis | 52.8 | 94 | Citations (PDF) |
| 420 | Vip Modulates Intracellular Calcium Oscillations in Human Lymphoblasts | 2.7 | 5 | Citations (PDF) |
| 421 | Odd forms of inflammatory bowel disease: What can they tell us? | 1.0 | 14 | Citations (PDF) |
| 422 | Distinct associations of HLA Class II genes with inflammatory bowel disease | 1.0 | 270 | Citations (PDF) |
| 423 | Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease | 1.9 | 3 | Citations (PDF) |
| 424 | Medical Treatment of Inflammatory Bowel Disease | 19.5 | 27 | Citations (PDF) |
| 425 | Reply | 1.0 | 6 | Citations (PDF) |
| 426 | Interleukin 8, neutrophils, and acute inflammation | 1.0 | 5 | Citations (PDF) |
| 427 | Reply | 1.0 | 2 | Citations (PDF) |
| 428 | Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity | 1.0 | 188 | Citations (PDF) |
| 429 | Ulcerative colitis-linked antineutrophil cytoplasmic antibody in the cotton-top tamarin model of colitis | 1.0 | 20 | Citations (PDF) |
| 430 | Biotinylation of a bombesin/gastrin-releasing peptide analogue for use as a receptor probe | 2.9 | 11 | Citations (PDF) |
| 431 | Anti-neutrophil cytoplasmic antibodies in ulcerative colitis | 1.0 | 301 | Citations (PDF) |
| 432 | Oral Mesalamine (Asacol) for Mildly to Moderately Active Ulcerative Colitis | 10.4 | 199 | Citations (PDF) |
| 433 | Neutrophil Cytoplasmic Antibodies: A Link Between Primary Sclerosing Cholangitis and Ulcerative Colitis | 1.0 | 337 | Citations (PDF) |
| 434 | Role of mucosal T-cell-generated cytokines in epithelial cell injury | 2.8 | 19 | Citations (PDF) |
| 435 | Neutrophil autoantibodies as disease markers for ulcerative colitis | 2.8 | 16 | Citations (PDF) |
| 436 | Prevalence and severity of periodontal disease in patients with inflammatory bowel disease | 6.6 | 64 | Citations (PDF) |
| 437 | Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis | 1.0 | 95 | Citations (PDF) |
| 438 | Sulfasalazine inhibits the binding of TNFα to its receptor | 3.7 | 70 | Citations (PDF) |
| 439 | A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease | 6.2 | 519 | Citations (PDF) |
| 440 | Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease | 4.4 | 26 | Citations (PDF) |
| 441 | Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease | 1.0 | 80 | Citations (PDF) |
| 442 | Enhanced neutrophil chemiluminescence in familial mediterranean fever | 4.4 | 25 | Citations (PDF) |
| 443 | Neuroendocrine modulation of the immune system | 2.3 | 89 | Citations (PDF) |
| 444 | Role of the CD45 (T-200) molecule in anti-CD3-triggered T cell-mediated cytotoxicity | 2.6 | 4 | Citations (PDF) |
| 445 | Hermansky-Pudlak syndrome: an immunologic assessment of 15 cases | 2.3 | 44 | Citations (PDF) |
| 446 | Human mucosal T-cell cytotoxicity | 1.0 | 46 | Citations (PDF) |
| 447 | Human mucosal cytotoxic effector cells | 1.0 | 51 | Citations (PDF) |
| 448 | Modulation of ongoing human immunoglobulin synthesis by natural killer cells | 2.6 | 36 | Citations (PDF) |
| 449 | Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes | 3.7 | 26 | Citations (PDF) |
| 450 | The pancreas, primary biliary cirrhosis and the dry gland syndrome | 1.3 | 1 | Citations (PDF) |
| 451 | Mast cell heterogeneity | 1.8 | 42 | Citations (PDF) |
| 452 | The influence of endorphins on peritoneal and mucosal mast cell secretion | 6.2 | 57 | Citations (PDF) |
| 453 | Endoscopic sphincterotomy | 1.3 | 2 | Citations (PDF) |
| 454 | Successful Endoscopic Removal of a Common Bile Duct Foreign Body | 2.3 | 9 | Citations (PDF) |
| 455 | Sonolucent Biliary Cast Preventing Endoscopic Sphincterotomy | 2.3 | 2 | Citations (PDF) |
| 456 | The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic levelGut, 0, , gutjnl-2016-313627 | 21.2 | 420 | Citations (PDF) |
| 457 | Microbiota regulates visceral pain in the mouse | 1.6 | 148 | Citations (PDF) |
| 458 | Social interaction-induced activation of RNA splicing in the amygdala of microbiome-deficient mice | 1.6 | 84 | Citations (PDF) |
